NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Research in the area of breast cancer reported from M.M. Gaudet and colleagues



April 3rd, 2008

"Background p53 participates in cell cycle control, programmed cell death/apoptosis, and DNA repair, all pathways involved in carcinogenesis. TP53 variants may influence p53 function," researchers in the United States report.

" We evaluated whether three well-characterized TP53 variants-Ex4 + 119 C> G (rs#1042522, Arg72Pro), IVS6 + 62 A> G (rs#1625895), and an IVS3 16 bp insertion/ deletion (INDEL; rs#17878362)-were associated with breast cancer risk in a population-based case-control study. Genotypes and haplotypes were determined using long-range PCR in a sample of 578 cases and 390 controls. For the Ex4 + 19 C> G SNP (rs1042522), women with the...


Source: Women's Health Weekly (2008-04-03)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login